Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update

PRINCETON, N.J., Sept. 28, 2026 // -- Palatin Technologies, Inc. (Nasdaq: PTN), a biopharmaceutical company developing medicines that target the melanocortin receptor ("MCR") system, today reported financial results for the fiscal year ended June 30, 2026 and provided an update on its MC4…